Skip to content

Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis

Microcirculatory Changes During Open Label Magnesium Sulphate Infusion in Severe Sepsis and Septic Shock

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01332734
Enrollment
14
Registered
2011-04-11
Start date
2010-03-31
Completion date
2011-01-31
Last updated
2011-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock, Severe Sepsis

Keywords

microcirculation, SDF, magnesium sulfate

Brief summary

During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed. Restoration of bloodpressure and cardiac performance may not be sufficient to correct these alterations. Magnesium is a potent vasodilator which may be used to open up the small vessels, in order to reduce organ failure.

Detailed description

In a single-center open label study we evaluated the effects of magnesium sulphate (MgS) infusion on the sublingual microcirculation perfusion in fluid resuscitated patients with severe sepsis and septic shock within the first 48 hours after ICU admission. Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Interventions

DRUGMagnesium Sulfate

2 gram in 1 hour

Sponsors

Lithuanian University of Health Sciences
CollaboratorOTHER
Frisius Medisch Centrum
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* severe sepsis and septic shock

Exclusion criteria

* pregnancy * oral bleeding * age \< 18 years * liver cirrhosis * acute arrhythmias * advanced malignancy or a mean arterial pressure (MAP) \< 65 mmHg refractory to vasopressors

Design outcomes

Primary

MeasureTime frameDescription
microvascular flow index1 hourDirectly prior to and after 1 hour of magnesium sulphate (MgS) infusion (2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.

Countries

Lithuania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026